523345 Before You Click “Print”: Regulatory Considerations for 3D Printed Oral Drug Products

Ahmed Zidan1, Alaadin Alayoubi1, James Coburn1, Bahaa Ghammraoui1, Celia N. Cruz2 and Muhammad Ashraf1, (1)FDA, Silver Spring, MD, (2)Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, MD
See more of this Session: 3D Printing II
See more of this Group/Topical: Topical Conference: Next-Gen Manufacturing